A new documentary, 'The Pink Pill,' explores the arduous journey of flibanserin (Addyi), often called 'female Viagra,' revealing the systemic gender bias, regulatory hurdles, and societal indifference that plagued its approval and accessibility for women struggling with low libido.
The article details the decade-long struggle of flibanserin, marketed as Addyi and often dubbed 'female Viagra,' to gain approval and widespread use for women experiencing Hypoactive Sexual Desire Disorder (HSDD). It begins with patient Barbara Gattuso's transformative experience in a 2010 clinical trial, where the drug, originally an antidepressant, showed promise in restoring female libido. The documentary 'The Pink Pill: Sex, Drugs & Who Has Control' exposes the numerous obstacles Addyi faced, including regulatory roadblocks from the FDA, pharmaceutical price-gouging, and profound societal disinterest in female sexual health beyond reproduction. Entrepreneur Cindy Eckert bought flibanserin in 2011 after its original developer, Boehringer Ingelheim, abandoned it. Eckert's company, Sprout Pharmaceuticals, successfully completed trials, but the FDA initially rejected the drug, citing side effects like dizziness and nausea, and displaying what critics called a 'paternalistic attitude.' The article contrasts this with the swift acceptance of Viagra for men, highlighting the medical establishment's apathy towards female libido. Despite eventually gaining FDA approval in 2015, Addyi was burdened with a severe 'black box' warning and strict prescribing rules, including an alcohol ban, unlike male sexual dysfunction drugs. After being sold to Valeant, its price skyrocketed, and it was eventually shelved, only for Eckert to buy it back. The film and article argue that the battle for Addyi's acceptance underscores a stubborn double standard in healthcare, where male sexual dysfunction is deemed essential to treat, but female pleasure and choice are dismissed. This struggle for bodily autonomy, the director Aisling Chin-Yee emphasizes, is intrinsically linked to broader contemporary issues like reproductive rights.
